Similar articles for PMID: 20550549

Year	Number of Results
1888	1
1980	1
1983	1
1986	1
1991	1
1997	1
1999	1
2000	1
2003	5
2004	2
2005	6
2006	7
2007	3
2008	4
2009	9
2010	12
2011	18
2012	12
2013	12
2014	12
2015	4
2016	8
2017	7
2018	6
2019	6
2020	6
2021	10
2022	14
2023	7
2024	0

1

Pharmacokinetics and safety of subcutaneous immune globulin (human), 10% caprylate/chromatography purified in patients with primary immunodeficiency disease.

Wasserman RL, Irani AM, Tracy J, Tsoukas C, Stark D, Levy R, Chen J, Sorrells S, Roberts R, Gupta S. Wasserman RL, et al. Clin Exp Immunol. 2010 Sep;161(3):518-26. doi: 10.1111/j.1365-2249.2010.04195.x. Clin Exp Immunol. 2010. PMID: 20550549 Free PMC article. Clinical Trial.

2

Pharmacokinetics, Safety, and Tolerability of Subcutaneous Immune Globulin Injection (Human), 10 % Caprylate/Chromatography Purified (GAMUNEX®-C) in Pediatric Patients with Primary Immunodeficiency Disease.

Heimall J, Chen J, Church JA, Griffin R, Melamed I, Kleiner GI. Heimall J, et al. J Clin Immunol. 2016 Aug;36(6):600-9. doi: 10.1007/s10875-016-0311-4. Epub 2016 Jun 25. J Clin Immunol. 2016. PMID: 27342758 Clinical Trial.

3

Immune globulin subcutaneous, human - klhw 20% for primary humoral immunodeficiency: an open-label, Phase III study.

Sleasman JW, Lumry WR, Hussain I, Wedner HJ, Harris JB, Courtney KL, Mondou E, Lin J, Stein MR. Sleasman JW, et al. Immunotherapy. 2019 Nov;11(16):1371-1386. doi: 10.2217/imt-2019-0159. Epub 2019 Oct 17. Immunotherapy. 2019. PMID: 31621458 Free article. Clinical Trial.

4

A multi-centre study of efficacy and safety of Intratect®, a novel intravenous immunoglobulin preparation.

Kreuz W, Erdös M, Rossi P, Bernatowska E, Espanol T, Maródi L. Kreuz W, et al. Clin Exp Immunol. 2010 Sep;161(3):512-7. doi: 10.1111/j.1365-2249.2010.04187.x. Clin Exp Immunol. 2010. PMID: 20550545 Free PMC article. Clinical Trial.

5

Immune globulin (human) 10 % liquid: a review of its use in primary immunodeficiency disorders.

McCormack PL. McCormack PL. BioDrugs. 2013 Aug;27(4):393-400. doi: 10.1007/s40259-013-0044-3. BioDrugs. 2013. PMID: 23703447 Review.

6

Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiency.

Wasserman RL, Melamed I, Stein MR, Gupta S, Puck J, Engl W, Leibl H, McCoy B, Empson VG, Gelmont D, Schiff RI; IGSC, 10% with rHuPH20 Study Group. Wasserman RL, et al. J Allergy Clin Immunol. 2012 Oct;130(4):951-7.e11. doi: 10.1016/j.jaci.2012.06.021. Epub 2012 Jul 28. J Allergy Clin Immunol. 2012. PMID: 22846381 Clinical Trial.

7

Pharmacokinetics and tolerability of a new intravenous immunoglobulin preparation, IGIV-C, 10% (Gamunex, 10%).

Ballow M, Berger M, Bonilla FA, Buckley RH, Cunningham-Rundles CH, Fireman P, Kaliner M, Ochs HD, Skoda-Smith S, Sweetser MT, Taki H, Lathia C. Ballow M, et al. Vox Sang. 2003 Apr;84(3):202-10. doi: 10.1046/j.1423-0410.2003.00286.x. Vox Sang. 2003. PMID: 12670369 Clinical Trial.

8

Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20 % in Patients with Primary Immunodeficiency Diseases in North America.

Suez D, Stein M, Gupta S, Hussain I, Melamed I, Paris K, Darter A, Bourgeois C, Fritsch S, Leibl H, McCoy B, Gelmont D, Yel L. Suez D, et al. J Clin Immunol. 2016 Oct;36(7):700-12. doi: 10.1007/s10875-016-0327-9. Epub 2016 Aug 31. J Clin Immunol. 2016. PMID: 27582171 Free PMC article. Clinical Trial.

9

Pharmacokinetics of subcutaneous IgPro20 in patients with primary immunodeficiency.

Wasserman RL, Melamed I, Nelson RP Jr, Knutsen AP, Fasano MB, Stein MR, Rojavin MA, Church JA. Wasserman RL, et al. Clin Pharmacokinet. 2011 Jun;50(6):405-14. doi: 10.2165/11587030-000000000-00000. Clin Pharmacokinet. 2011. PMID: 21553933 Clinical Trial.

10

Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trial.

Roifman CM, Schroeder H, Berger M, Sorensen R, Ballow M, Buckley RH, Gewurz A, Korenblat P, Sussman G, Lemm G. Roifman CM, et al. Int Immunopharmacol. 2003 Sep;3(9):1325-33. doi: 10.1016/s1567-5769(03)00134-6. Int Immunopharmacol. 2003. PMID: 12890430 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

161 results

Results by year